Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Leap Therapeutics Inc
LPTXCurrent price
2.89 USD
-0.11 USD (-3.67%)
Last closed
3.25 USD
Company
www.leaptx.com
ISIN
US52187K1016
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
123 976 984 USD
Yield for 12 month
+80.63 %
1Y
3Y
5Y
10Y
15Y
LPTX
Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops antibody therapies for the treatment of cancer. Its lead product candidates include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric and gynecologic cancers; and FL-301, a monoclonal antibody that targets cells that express Claudin18.2 on their cell surface and is in phase II clinical trial, as well as two preclinical antibody programs, FL-302 and FL-501. Leap Therapeutics, Inc. has an option and license agreement with NovaRock, Adimab, and BeiGene, Ltd. to develop and commercialize DKN-01 in Asia (excluding Japan), Australia, and New Zealand. The company was formerly known as HealthCare Pharmaceuticals, Inc. and changed its name to Leap Therapeutics, Inc. in November 2015. Leap Therapeutics, Inc. was incorporated in 2011 and is based in Cambridge, Massachusetts. Address: 47 Thorndike Street, Cambridge, MA, United States, 02141
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
11.38 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
+375 000 USD
Current Quarter
–
Last Quarter
–
Current Year
-427 000 USD
Last Year
-415 000 USD
Current Quarter
–
Last Quarter
-5 000 USD
Key Figures LPTX
1 year
3 years
5 years
10 years
EBITDA
-64 688 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-45.62 %
PEG Ratio
0.75
Return On Equity TTM
-80.54 %
Wall Street Target Price
11.38 USD
Revenue TTM
375 000 USD
Book Value
1.72 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
1 500 000 USD
Earnings per share
-0.98 USD
Diluted Eps TTM
-0.98 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics LPTX
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History LPTX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:10
Payout Ratio
–
Last Split Date
21.06.2023
Dividend Date
–
Stock Valuation LPTX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
1.8965
Price Sales TTM
160.1041
Enterprise Value EBITDA
0.4706
Price Book MRQ
1.8845
Financials LPTX
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators LPTX
For 52 weeks
1.34 USD
5 USD
50 Day MA
2.92 USD
Shares Short Prior Month
899 103
200 Day MA
2.67 USD
Short Ratio
4.96
Shares Short
723 536
Short Percent
2.25 %
BeatStart